Literature DB >> 15023865

Sponge-induced angiogenesis and inflammation in PAF receptor-deficient mice (PAFR-KO).

Mônica A N D Ferreira1, Lucíola S Barcelos, Paula P Campos, Anilton C Vasconcelos, Mauro M Teixeira, Silvia P Andrade.   

Abstract

1. To determine biological functions of platelet-activating factor (PAF) in chronic inflammation, we have investigated the kinetics of angiogenesis, inflammatory cells recruitment and cytokine production in sponge-induced granuloma in wild type and PAF receptor-deficient mice (PAFR-KO). 2. Angiogenesis as determined by morphometric analysis and hemoglobin content was significantly higher in the implants of PAFR-KO mice at all time points. Treatment with PAF receptor antagonist UK74505 (30 mg kg(-1)) also increased angiogenesis in sponge implants. 3. Neutrophils and macrophages accumulation, as determined by myeloperoxidase and N-acetylglucosaminidase activities in the supernatant of implanted sponges were markedly decreased in PAFR-KO mice. Surprisingly, the levels of the proinflammatory chemokines, keratinocyte-derived chemokine and chemokine monocyte chemoattractant protein 1 were higher in the implants of the transgenic animals. 4. We have shown that angiogenesis was stimulated in PAFR-KO mice whereas inflammation was decreased, indicating that PAF is an endogenous regulator of new blood vessels formation in the inflammatory microenvironment induced by the sponge implant.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15023865      PMCID: PMC1574894          DOI: 10.1038/sj.bjp.0705731

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  37 in total

1.  Platelet-activating factor (PAF) induces growth stimulation, inhibition, and suppression of oncogenic transformation in NRK cells overexpressing the PAF receptor.

Authors:  K Kume; T Shimizu
Journal:  J Biol Chem       Date:  1997-09-05       Impact factor: 5.157

2.  Platelet-activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism.

Authors:  G Camussi; G Montrucchio; E Lupia; A De Martino; L Perona; M Arese; A Vercellone; A Toniolo; F Bussolino
Journal:  J Immunol       Date:  1995-06-15       Impact factor: 5.422

3.  Sponge-induced angiogenesis in mice and the pharmacological reactivity of the neovasculature quantitated by a fluorimetric method.

Authors:  S P Andrade; R D Machado; A S Teixeira; A V Belo; A M Tarso; W T Beraldo
Journal:  Microvasc Res       Date:  1997-11       Impact factor: 3.514

Review 4.  Chemokines.

Authors:  B J Rollins
Journal:  Blood       Date:  1997-08-01       Impact factor: 22.113

5.  The role of platelet activating factor and other lipid mediators in inflammatory angiogenesis.

Authors:  J R Jackson; B Bolognese; C A Mangar; W C Hubbard; L A Marshall; J D Winkler
Journal:  Biochim Biophys Acta       Date:  1998-05-20

Review 6.  The codependence of angiogenesis and chronic inflammation.

Authors:  J R Jackson; M P Seed; C H Kircher; D A Willoughby; J D Winkler
Journal:  FASEB J       Date:  1997-05       Impact factor: 5.191

Review 7.  Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine.

Authors:  L F Brown; M Detmar; K Claffey; J A Nagy; D Feng; A M Dvorak; H F Dvorak
Journal:  EXS       Date:  1997

8.  Platelet-activating factor exerts mitogenic activity and stimulates expression of interleukin 6 and interleukin 8 in human lung fibroblasts via binding to its functional receptor.

Authors:  M Roth; M Nauck; S Yousefi; M Tamm; K Blaser; A P Perruchoud; H U Simon
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

9.  Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor.

Authors:  S Ishii; T Kuwaki; T Nagase; K Maki; F Tashiro; S Sunaga; W H Cao; K Kume; Y Fukuchi; K Ikuta; J Miyazaki; M Kumada; T Shimizu
Journal:  J Exp Med       Date:  1998-06-01       Impact factor: 14.307

10.  Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis.

Authors:  F Bussolino; M Arese; G Montrucchio; L Barra; L Primo; R Benelli; F Sanavio; M Aglietta; D Ghigo; M R Rola-Pleszczynski
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

View more
  9 in total

1.  Cytokines and neutrophils as important mediators of platelet-activating factor-induced kinin B1 receptor expression.

Authors:  Elizabeth S Fernandes; Giselle F Passos; Maria M Campos; Glória E P de Souza; Juliana F Fittipaldi; Jorge L Pesquero; Mauro M Teixeira; João B Calixto
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

Review 2.  A critical analysis of current in vitro and in vivo angiogenesis assays.

Authors:  Carolyn A Staton; Malcolm W R Reed; Nicola J Brown
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

3.  Treatment with Atorvastatin Provides Additional Benefits to Imipenem in a Model of Gram-Negative Pneumonia Induced by Klebsiella pneumoniae in Mice.

Authors:  Talles Prosperi de Paula; Patrícia Campi Santos; Raquel Duque do Nascimento Arifa; Angélica T Vieira; Ludmila de Matos Baltazar; Thiago Vinícius Ávila; Caio Tavares Fagundes; Zélia Menezes Garcia; Renata Lacerda Lima; Mauro Martins Teixeira; Danielle G Souza
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

4.  Receptor binding mode and pharmacological characterization of a potent and selective dual CXCR1/CXCR2 non-competitive allosteric inhibitor.

Authors:  R Bertini; L S Barcelos; A R Beccari; B Cavalieri; A Moriconi; C Bizzarri; P Di Benedetto; C Di Giacinto; I Gloaguen; E Galliera; M M Corsi; R C Russo; S P Andrade; M C Cesta; G Nano; A Aramini; J C Cutrin; M Locati; M Allegretti; M M Teixeira
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

5.  Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient mice.

Authors:  Kent Doi; Koji Okamoto; Kousuke Negishi; Yoshifumi Suzuki; Akihide Nakao; Toshiro Fujita; Akiko Toda; Takehiko Yokomizo; Yoshihiro Kita; Yasuyuki Kihara; Satoshi Ishii; Takao Shimizu; Eisei Noiri
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

6.  Blockade of cannabinoid receptors reduces inflammation, leukocyte accumulation and neovascularization in a model of sponge-induced inflammatory angiogenesis.

Authors:  Rodrigo Guabiraba; Remo C Russo; Amanda M Coelho; Mônica A N D Ferreira; Gabriel A O Lopes; Ariane K C Gomes; Silvia P Andrade; Luciola S Barcelos; Mauro M Teixeira
Journal:  Inflamm Res       Date:  2013-05-31       Impact factor: 4.575

7.  Foreign body response to subcutaneous implants in diabetic rats.

Authors:  Teresa Oviedo Socarrás; Anilton C Vasconcelos; Paula P Campos; Nubia B Pereira; Jessica P C Souza; Silvia P Andrade
Journal:  PLoS One       Date:  2014-11-05       Impact factor: 3.240

8.  Safer topical treatment for inflammation using 5α-tetrahydrocorticosterone in mouse models.

Authors:  Annalisa Gastaldello; Dawn E W Livingstone; Amber J Abernethie; Nicola Tsang; Brian R Walker; Patrick W F Hadoke; Ruth Andrew
Journal:  Biochem Pharmacol       Date:  2017-01-24       Impact factor: 5.858

9.  Systemic Platelet-Activating Factor-Receptor Agonism Enhances Non-Melanoma Skin Cancer Growth.

Authors:  Eric Romer; Anita Thyagarajan; Smita Krishnamurthy; Christine M Rapp; Langni Liu; Katherine Fahy; Azeezat Awoyemi; Ravi P Sahu
Journal:  Int J Mol Sci       Date:  2018-10-11       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.